The NIH's National Institute of Allergy and Infectious Diseases has awarded a $36 million grant to Beth Israel Deaconess Medical Center to spearhead a consortium that aims to study AIDS vaccines in nonhuman primates. The grant will be distributed over five years. "The goal of the consortium is to elucidate the earliest immunologic and pathologic events at mucosal surfaces following virus infection, and to determine the ability of multiple leading vaccine candidates to block or to attenuate these events," said Dr. Dan Barouch, chief of vaccine research at Beth Israel.

Related Summaries